All News

Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges

Dr. George Vratsanos, rheumatologist and Executive Global Program Head at Novartis Pharmaceuticals, shares his team’s top five principles that are at the heart of our clinical trial program.

We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.

With ViaOpta Nav, visually impaired people can now use Apple watches and Android Wear devices to navigate to and from places with greater ease.